BDBM391201 2-((3R,4R or 3S,4S)-4-(3- ((1,1-dioxido-2-(piperidin-4- yl)-2,3-dihydrobenzo [d]isothiazol-5- yl)amino)-4-oxo-4,5- dihydro-1H-pyrazolo[4,3- c]pyridin-1-yl)-3- fluorotetrahydro-2H-pyran- 4-yl)acetonitrile (from I- 22A)::US9957264, Example 5-272

SMILES N#CC[C@@]1(n2nc(Nc3ccc4c(c3)CN(C3CCNCC3)S4(=O)=O)c3c(=O)[nH]ccc32)CCOC[C@@H]1F

InChI Key InChIKey=MONOVCADVPANKP-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 391201   

TargetTyrosine-protein kinase JAK1(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 391201BDBM391201(US9957264, Example 5-272 | 2-((3R,4R or 3S,4S)-4-(...)
Affinity DataIC50: 0.0600nMAssay Description:The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 391201BDBM391201(US9957264, Example 5-272 | 2-((3R,4R or 3S,4S)-4-(...)
Affinity DataIC50: 0.100nMAssay Description:The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2020
Entry Details
US Patent